The Union Health Ministry has included the use of which anti-viral drug as part of investigational therapy only for restricted emergency-use in its updated Clinical Management Protocol for Covid-19 patients?

2020

Please wait while the activity loads.
If this activity does not load, try refreshing your browser. Also, this page requires javascript. Please visit using a browser with javascript enabled.

If loading fails, click here to try again

Question [CLICK ON ANY CHOICE TO KNOW THE RIGHT ANSWER]

The Union Health Ministry has included the use of which anti-viral drug as part of “investigational therapy” only for restricted emergency-use in its updated Clinical Management Protocol for Covid-19 patients?

A	Trizivir
B	Peramivir
C	Remdesivir
D	Indinavir

Explanation:

Detailed explanation-1: -In the protocol, remdesivir is listed as an investigational therapy, i.e. where informed and shared decision making is essential, besides taking note of contra indications mentioned in the detailed guidelines, the ministry said.

Detailed explanation-2: -Remdesivir is an antiviral medicine that works against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This medicine is to be given only by or under the immediate supervision of your doctor. This product is available in the following dosage forms: Solution.

Detailed explanation-3: -Remdesivir is an inhibitor of the SARS-CoV-2 RNA-dependent RNA polymerase (RdRp), which is essential for viral replication. Remdesivir is an adenosine nucleotide prodrug that is metabolized to the pharmacologically active nucleoside triphosphate metabolite after being distributed into cells.

Detailed explanation-4: -Remdesivir is used to treat COVID-19 infection caused by the SARS-CoV-2 virus. It stops the COVID virus from spreading in the body and causing severe disease.

There is 1 question to complete.